Quick Answer
Context Therapeutics Inc. reported Net Income of -$36.12 million for fiscal year 2025.
Context Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$36.12M | -35.2% |
| 2024 | -$26.73M | -11.5% |
| 2023 | -$23.96M | -61.5% |
| 2022 | -$14.84M | -41.9% |
| 2021 | -$10.46M | -257.4% |
| 2020 | $6.64M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$9.69M | +44.5% | -9.8% |
| June 30, 2025 | -$8.83M | -291.5% | -92.9% |
| March 31, 2025 | -$4.58M | -24.8% | +73.8% |
| September 30, 2024 | -$17.46M | -197.2% | -674.4% |
| June 30, 2024 | -$2.25M | +55.0% | +38.5% |
| March 31, 2024 | -$3.67M | +41.9% | +37.6% |
| September 30, 2023 | -$5.87M | -52.4% | -17.2% |
| June 30, 2023 | -$5.01M | -25.7% | +20.6% |
- Context Therapeutics Inc. showed a decrease of -35.2% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Context Therapeutics Inc.’s net income has declined by 643.7% (from $6.64 million to -$36.12 million).
- The most recent figure is from Context Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: